Skip to main content

Table 5 The serial change in mean value (SD) of frequency volume chart

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Variable

Baseline

1 month

3 months

6 months

12 months

Total volume (mL/day)

Naftopidil (n=70)

1915 (756)

1871 (745)

1782** (533)

1718** (652)

1687** (562)

Silodosin (n=71)

1777 (573)

1862 (610)

1569** (583)

1633** (634)

1652** (564)

Total (n=141)

1846 (672)

1866 (680)

1675** (576)

1676** (642)

1670** (561)

24-hour urinary frequency

Naftopidil (n=70)

9.2 (2.4)

12.0** (3.9)

12.6** (3.9)

11.4** (3.7)

10.0** (2.5)

Silodosin (n=71)

9.2 (2.4)

12.3** (3.5)

11.8** (3.1)

11.2** (3.6)

10.3** (3.2)

Total (n=141)

9.2 (2.4)

12.2** (3.7)

12.2** (3.5)

11.3** (3.6)

10.1** (2.9)

Mean voided vol (mL)

Naftopidil (n=70)

215 (84)

165** (66)

151** (60)

157** (58)

177** (71)

Silodosin (n=71)

199 (66)

159** (56)

140** (57)

153** (55)

168** (64)

Total (n=141)

207 (76)

162** (61)

145** (58)

155** (57)

173** (67)

  1. *p < 0.05, **p < 0.01.